CalciMedica Advances Auxora and CM5480 in Pulmonary Hypertension
LA JOLLA, Calif., August 11, 2026 CalciMedica, Inc. reported its second-quarter 2026 financial results and provided updates across its...
pulmonary hypertension
Advertisement
Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103
Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...
Gossamer Bio Reacquires Global Rights to Seralutinib
San Diego, California, July 27, 2026 Gossamer Bio, Inc. announced a series of significant regulatory, strategic, and financial milestones...
Tenax Therapeutics to Present LEVEL Phase 3 Data at ESC
CHAPEL HILL, N.C., July 2, 2026 Tenax Therapeutics, Inc. announced that results from its Phase 3 LEVEL clinical trial...
CalciMedica Secures $49M Financing to Advance PH Program
LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. (Nasdaq: CALC) announced a private placement financing of up to approximately...
Advertisement
